Fig. 1

C1GALT1 is upregulated in GC tissues and high expression of C1GALT1 predicts poor prognosis for GC patients. a Bioinformatics analysis of C1GALT1 mRNA expression in 33 types of cancers using the TCGA and GTEx databases (p = 0.005, Mann–Whitney U test). b qRT-PCR analysis of C1GALT1 expression in paired GC tissues and their adjacent non-tumor tissues (p = 0.0173, Mann–Whitney U test). c Western blot analysis of C1GALT1 expression in paired GC tissues and their adjacent non-tumor tissues (p = 0.0269, Mann–Whitney U test). d Representative images and quantitative analysis of C1GALT1 staining. Scale bars, 100 μm (p = 0.0146, Mann–Whitney U test). e Kaplan–Meier analysis of overall survival in GC patients according to C1GALT1 expression (p = 0.0032, Kaplan–Meier method with log-rank test). f Kaplan–Meier survival curves of C1GALT1 in GC patients generated from the Kaplan–Meier plotter (p = 0.0036, Kaplan–Meier method with log-rank test). STAD: stomach adenocarcinoma; T: tumor tissue; N: normal or non-tumor tissue